Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2000

View Archived Issues

Bausch & Lomb reports progress with breakthrough treatment for serious eye diseases

ImmunoGen and Genentech sign TAP license agreement

Multiple positive cardiac effects established for Novogen's NV-04

Orphan drug status awarded to arsenic trioxide for multiple myeloma

CDD and ICRT to collaborate on anticancer drug development

Oxford BioMedica acquires development rights to nitroreductase genes

Special access program approved for Visudyne in Canada

Optison litigation ends, new agreements concerning ultrasound products reached

Novavax enters licensing option for metronidazole analogues

Multikine shows promising efficacy and safety in phase II trial

Orion updates product pipeline

Biomira makes progress with therapeutic cancer vaccines

Oxigene makes solid progress during Q1 2000

Clasp-1: a novel transmembrane protein localized at the interface of T- and B-cell clusters

Specially designed contrast agents for tumors reported by Schering

Chiron and collaborators develop potential new treatments for meningitis and sepsis

Multitarget antiinflammatory agents designed at Merckle

HMW endostatins for treatment and diagnosis of tumors disclosed by Haemopep

New NPS compounds interact with a novel site on receptor-operated Ca2+ channels

Antitumor agents from American Cyanamid act by inhibiting PTKs

Kinase inhibitors under evaluation at major German pharmaceutical laboratory

Eisai investigates selective RARalpha agonists for dermatologic, immunologic disorders

Patients with ovarian cancer sought for phase III trial

New VLA-4 antagonist designed at Celltech is a potent, orally active antiasthmatic agent

Multiple mechanisms of action endow new compound with potent activity in models of COPD and asthma

Investigational anticoagulant H-376/95/melagatran given wide coverage at recent congress

Atlantic to begin clinical trials of synthetic derivative of marijuana

Modafinil proves useful for improving multiple sclerosis-related fatigue

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...